Psychosis
335
58
74
157
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
40 trials with published results (12%)
Research Maturity
157 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
18 terminated out of 335 trials
89.7%
+3.2% vs benchmark
10%
32 trials in Phase 3/4
25%
40 of 157 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 157 completed trials
Clinical Trials (335)
The Mouth Matters in Mental Health Trial -2
Determining the Role of Social Reward Learning in Social Anhedonia
Tele-group Cognitive Behavioural Family Intervention for People With Schizophrenia and Their Families (Feasibility tgCBFI)
Cognitive Strategies in Early Psychosis 2
TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis
Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
A Case Series of Culturally-adapted CBTp for Black People in the UK
EPI-MINN: Targeting Cognition and Motivation - National
Mentalization Based Treatment (MBT) in Help Seeking Youths With a Clinical High-Risk Condition for Psychosis (CHR-P)
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Open Label Extension Study of NCT06221852
Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis
Online Intervention To Improve Motivation
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
Semantic and Syntactic Computerized Analysis of Free Speech
Strengthening Care in Collaboration With People With Lived Experience of Psychosis in Uganda
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2